The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
Meet the Team
Global Vice President
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in the following strategic and operational areas.
Pharmaceuticals & Biotech
Competitive analysis series covering: oncology, diabetes/metabolic diseases, neurology, cardiovascular diseases and infectious diseases.
In Vitro Diagnostics & Research Tools
Market analysis series covering: molecular Dx (incl. companion Dx), POCT, clinical lab services, next generation sequencing and chromatography/research antibodies.
Market insights series covering: regenerative medicine, biosimilars, generics 2.0, CRAMS, digital pathology, downstream bioprocessing and antibody drug conjugates.
- Innovating business models that promise sustainable revenue streams
- Designing integrated data platforms that empower consumers
- Developing strategic partnerships that bring novel products and services to the market
- Establishing industry best practices
- Identifying emerging markets opportunities
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large…
This Drug Discovery TOE depicts trends across RNA technology driving a new wave of therapeutics. Different, stable, non-Immunogenic mRNA therapies, targeted RNAi technologies and therapeutics, CAR T-cell therapy, antisense therapeutics, RNA-based delivery platforms, and DNA-directed RNAi approaches…
This Genetic Technology TOE depicts life sciences trends across medical genetic technologies. Particular emphasis is focused on tissue regeneration and gene editing technologies. Clinical trials of stem cells is also presented.
The Genetic Technology TechVision Opportunity Engine (TOE) presents…
This Genetic Technology TOE encompasses recent advances in artificial intelligence platforms enabling drug discovery and development, while highlighting the importance of explainability in AI-driven technologies for healthcare. The TOE also provides an overview of the AI value chain.
The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized,…
Innovations in Drug Delivery, Cancer Immunotherapies, Biomarker Identification, and Gene Therapy for Preventing Vision Loss
This Genetic Technology TOE depicts life sciences trends across drug delivery platforms, cancer immunotherapies, biomarker identification, and gene therapy. Among the therapeutic areas in focus, age-related macular degeneration (AMD), aggressive childhood cancers, and bladder cancer, are of note.…
As healthcare evolves toward personalized solutions, everyday consumers are proactively taking responsibility for their health in ways unimaginable a decade ago. A direct-to-consumer genetic test (DTCGT) exemplifies this trend which can be purchased and used directly by consumers without the…
This Genetic Technology TOE depicts life sciences trends across digital innovations, including, digital genomics and artificial intelligence (AI)-driven medicine. Clinical trials for Propeller Health Platform is also depicted.
The Genetic Technology TechVision Opportunity Engine (TOE) presents…
Diagnostics has inarguably become an integral part of healthcare system, moving from reactionary science to predictive science; playing a vital role throughout the care continuum. While rising burden of chronic diseases, drug-resistant diseases and the increasing proportion of elderly population are…
This Genetic Technology TOE provides insights into recent developments across stem cell technologies. It encompasses innovations in delivery platforms, iPSC therapeutics, bioengineering methods, and mesenchymal stem cell therapies. The TOE also provides a summary of key stem cell therapies.
Frost & Sullivan's Growth Consulting services support our clients who require customized and collaborative solutions to help their companies meet revenue targets, capture market share and expand portfolios. Most projects are focused on addressing highly strategic challenges that require creative research techniques and deep market insights to address our clients’ specific needs. Our projects focus on ten primary areas:
Growth Consulting clients are primarily healthcare technology and service providers such as medical device and diagnostic companies, pharmaceutical and biotech manufacturers, and firms in the healthcare information technology and connected health markets. Companies supporting these firms, whether for professional services and logistics or components and software, also regularly turn to us for insight into the multi-billion dollar healthcare vertical. Our broad base of capabilities can be leveraged by any entity seeking to grow in the intersection between healthcare and technology innovation.
Recognizing each project as unique, Frost & Sullivan crafts the optimal approach to addressing our clients’ needs. These tools may include:
Why Partner with Frost & Sullivan?
- Deep subject matter expertise with highly educated consultants focusing entirely on the healthcare technology sector
- More than 45 locations around the world to provide unparalleled global access and insights
- Collaborative teams that formed across industry sectors supporting healthcare technology vertical, e.g. materials, mobility and wireless, power systems, sensors, software, logistics, transportation, food, and others
- Strong reputation and deep network of healthcare technology contacts to support rapid and insightful industry research and networking
- Decades of experience in epidemiological, financial, and competitive forecast modelling, providing quantitative rigor and to all our engagements
- Proven processes and methodologies tested across hundreds of projects with the world’s leading firms
- Creative thought leadership and deep insights into market dynamics to help product development teams and executives create and validate new whitespace opportunities
- Ability to design and facilitate on-site workshops with our clients which use proprietary exercises to evaluate opportunities, develop strategies and reach consensus on next steps
- An established brand known for excellence in the field of healthcare technology innovation that can be leveraged for custom whitepapers, e-broadcasts and other tactical marketing initiatives
- A highly-skilled team of quantitative research professionals capable of designing and executing complex methodologies, including conjoint analysis, MaxDiff, multivariate analysis and others
- Access to a broad network of affiliated service partners and third party data tools to extend our capabilities
|Types of Companies||Examples of Recent Projects|
|Healthcare Providers||Assessing Licensing Potential for an Enterprise Learning System of a Leading Tertiary Healthcare Provider|
|Suppliers/ Service Providers to Industry||Interactive Digital Whitepaper with Embedded Video on the Future of the Global Healthcare Products Supply Chain for a Major Logistics Company|
|Consumer Health||Competitive Profiles on 1,200+ Weight Loss and Skin Care Product Available Worldwide to Support R&D Efforts of a Major Competitor|
|Investors||Buy-Side Valuation Analysis and Financial Modeling for Investment Consideration in an Energy-Based Medical Device Start Up|
|Professional Associations||Annual Customer Survey on U.S. Purchasing Patterns for Laboratory Products Commissioned by a Leading Industry Association|
Frost & Sullivan’s Growth Workshops help clients establish a narrow portfolio of key market opportunities from a larger pool of options. These interactive sessions help clients identify the strongest opportunities in the market and brainstorm strategies for pursuing those opportunities. Growth Workshops run the gamut of market analysis, from opportunity identification to strategy development to planning and implementation. Each workshop’s design is based on the full breadth of client objectives and desired outcomes.
Growth Workshop Consultants help clients funnel and prioritize which opportunities fit best with the company's internal capabilities. During these workshops, attendees gain market knowledge and are trained on evaluation tools and techniques to translate market, competitive, technical, regulatory and economic implications into specific growth opportunities.
Frost & Sullivan’s Growth Workshops use a range of tools and exercises to help clients identify and prioritize key market opportunities, such as:
- Opportunity/Fit Matrix
- Decision Support Scorecard
- Strategy Mapping
- Executive Alignment Surveys
"Frost & Sullivan worked with Tissue and Eye Services (a division of NHS Blood and Transplant) to deliver an informed opinion on market potential and dynamics in the tissues market. Their thought leadership on market segmentation, market share and insights into what influenced customers buying behaviour enabled us to reassess our strategy and focus on products that would deliver growth. Their partnership approach worked for us and they were responsive to our challenge and questions in specific areas of interest."
"We have been very satisfied with the consulting project we commissioned with Frost & Sullivan. The analysts were responsive to our needs and accessible during the project. The finished research was quite thorough and, as we later saw, proved to be a highly accurate depiction of the market."
"We have found Frost & Sullivan’s work to be nothing short of excellent. The consulting project results were concise and cohesive, leading us to better understand a market that is usually complex and difficult to research."
"We have relied on Frost & Sullivan’s strategic research studies for reliable insights into several competitive markets. Their ability to identify and analyze industry-specific trends gives their clients not only a clear indication of where markets are going, but why they are going there."
"The team was knowledgeable and not only determined what information would be helpful in the long-term, but delivered it in a short amount of time. The study helped us make good strategic decisions, backed by reliable market-based information."
“It was great to talk to your analysts and grateful for everything you and the team do to support our company on a daily basis.”
Global Market Intelligence Manager, Medical Devices Company
"You are my most trusted source for information on a myriad of topics.”
Fortune 500 Company
"This looks very comprehensive and a huge piece of work. Definitively a vendor we can consider for some of our later stage assets."
Global Strategic Marketing, Oncology, Pharma Company